K
Klineo utilizes AI algorithms to match cancer patients with relevant clinical trials based on their medical profiles. The platform facilitates communication between patients, their oncologists, and trial investigators to streamline the enrollment process. This service increases patient access to novel therapies while helping to address under-recruitment issues in clinical research.
Paris, France
Updated 2 months ago
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Klineo utilizes AI algorithms to match cancer patients with relevant clinical trials, simplifying the search process. The platform allows patients to identify suitable trials and share them with their oncologists for discussion and potential inclusion. This service aims to increase patient participation in clinical research by streamlining access to novel therapies.